Observational studyVirology journal2024

Real-world clinical outcomes of tixagevimab/cilgavimab in the Omicron outbreak in China: baseline characteristics and interim analysis of the CLEAR study.

Jianhua You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.